Treatment persistence and compliance with a combination of calcium and vitamin D

References

• National Osteoporosis Foundation 2008. Clinician's guide to prevention and treatment of osteoporosis. http://www.nof.org/professionals/Clinicians_Guide.htm
   Google Scholar
• Melton LJ 3rd. How many women have osteoporosis now? J Bone Miner Res 1995;10:175–177
   PubMed Web of Science ®Google Scholar
• Melton LJ. Epidemiology worldwide. Endocrinol Metab Clin N Am 2003;32:1–13
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, et al Long-term risk of osteoporotic fracture in Malmo. Osteporos Int 2000;11:669–674
   PubMed Web of Science ®Google Scholar
• Petrella RJ, Jones TJ. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care? BMC Fam Pract 2006;7:31
   PubMedGoogle Scholar
• Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004;180:S18
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Tosteson AN, Melton LJ 3rd, et al National Osteoporosis Foundation Guide Committee. Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 2008;19:449–458
   PubMed Web of Science ®Google Scholar
• Kanis JA, Burlet N, Cooper C, et al European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399–428
   PubMed Web of Science ®Google Scholar
• Qaseem A, Snow V, Shekelle P, et al Pharmacologic treatment of low bone density of osteoporosis to prevent fractures: a clinical practice guideline from American College of Physicians. ACP Clinical Practice Guidelines. Ann Intern Med 2008;149:404–415
   PubMed Web of Science ®Google Scholar
• González J, Guañabens N, Gómez C, et al Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de investigación ósea y del metabolismo minireal. Rev Clin Española 2008;208:1–24
   PubMedGoogle Scholar
• O'Connell MB. Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis. J. Manag Care Pharm 2006;12:S10–19
   PubMed Web of Science ®Google Scholar
• Bruyère O, Malaise O, Neuprez A, et al Prevalence of vitamin D inadequacy in Europe postmenopausal women. Curr Med Res Opin 2007;23:1939–1944
   PubMed Web of Science ®Google Scholar
• Lips P, Hosking D, Lippuner K, et al The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006;260:245–254
   PubMed Web of Science ®Google Scholar
• Holick MF, Siris ES, Binkley N, et al Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215–3224
   PubMed Web of Science ®Google Scholar
• Boland R. Role of vitamin D in skeletal muscle function. Endocr Rev 1986;7:434–449
   PubMed Web of Science ®Google Scholar
• Brown SE. Vitamin D and fracture reduction: and evaluation of the existing research. Alt Med Rev 2008;13:21–33
   PubMed Web of Science ®Google Scholar
• Nieves JW, Komar L, Cosman F, et al Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nut 1998;67:18–24
   PubMed Web of Science ®Google Scholar
• Koster JC, Hackeng WH, Mulder H. Disminished effect of ethindronate in vitamin D deficient osteopenic postmenopausal women. Eur J Clin Pharmacol 1996;51:145–147
   PubMedGoogle Scholar
• Nordin BEC. Calcium and osteoporosis. Nutrition 1997;13:664–686
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Dallal GE, Krall EA, et al Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505–512
   PubMed Web of Science ®Google Scholar
• Boonen S, Vanderschueren D, Haentjens P, et al Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update. J Intern Med 2006;259:539–552
   PubMed Web of Science ®Google Scholar
• Jackson RD, LaCroix AZ, Gass M, et al Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669–683
   PubMed Web of Science ®Google Scholar
• Tang BM, Eslick GD, Nowson GD, et al Use of calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years or older: a meta-analysis. Lancet 2007;370:657–666
   PubMed Web of Science ®Google Scholar
• Zhu K, Devine A, Dick IM, et al Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analyzes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab 2008;93:743–749
   PubMed Web of Science ®Google Scholar
• Rossini M, Bianchi G, Di Mundo O, et al Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 2006;17:914–921
   PubMed Web of Science ®Google Scholar
• Tosteson AN, Grove MR, Hammond CS, et al Early discontinuation of treatment for osteoporosis. Am J Med 2003;115:209–216
   PubMed Web of Science ®Google Scholar
• Penning-van Beest FJ, Erkens JA, Olson M, et al Loss of treatment benefit due to low compliance with bisphosphonate therapy. Osteporos Int 2008;19:511–517
   PubMed Web of Science ®Google Scholar
• Rabenda V, Mertens R, Fabri V, et al Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008;19:811–818
   PubMed Web of Science ®Google Scholar
• Val Jiménez A, Amorós G, Martínez P, et al Estudio descriptivo del cumplimiento del tratamiento farmacológico antihipertensivo y validación del test de Morisky-Green. Aten Primaria 1992;10:767–770
   PubMedGoogle Scholar
• Weycker D, Macarios D, Edelsberg J, et al Compliance with drug therapy for postmenopausal osteoporosis. Osteoporos Int 2006;17:1645–1652
   PubMed Web of Science ®Google Scholar
• International Osteoporosis Foundation. The adherence gap: why osteoporosis patients don't continue with treatment. www.osteofound.org
   Google Scholar
• Nielsen D, Ryg J, Nissen N, et al Multidisciplinary patient education in groups increases knowledge on osteoporosis: a randomized controlled trail. Scand J Public Health 2008;36:346–352
   PubMed Web of Science ®Google Scholar
• Cooper A, Drake J, Brankin E. Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study. Int J Clin Prac 2006;60:869–905
   Google Scholar
• Cuddihy MT, Amadio PC, Gabriel SE, et al A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture. Osteoporos Int 2004;15:695–700
   PubMed Web of Science ®Google Scholar
• Cramer JA, Amonkar MM, Hebborn A, Altman R. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005;21:1453–1460
   PubMed Web of Science ®Google Scholar
• Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment on postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 2004;89:1117–1123
   PubMed Web of Science ®Google Scholar
• Gleeson T, Iversen MD, Avorn J, et al Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int 2009;Jun 5. Epub ahead print
   Web of Science ®Google Scholar
• Phinney KW, Sander KE, Sharpless EC, et al NIST develops serum-based standard reference materials to assess nutritional status. Chemical Science and Technology Laboratory, National Institute of Standards and Technology Food and Nutrition http://www.cstl.nist.gov/projects/fy06/food0683904.pdf
   Google Scholar